Blunted erythropoietin response to anaemia in tuberculosis

European Journal of Haematology

Volumn 55, Issue 4, 1995, Pages 251-254

  Ebrahim, O ^a   Folb, P I ^a   Robson, S C ^b   Jacobs, P ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

anaemia; erythropoietin; pulmonary tuberculosis; tumour necrosis factor alpha

Indexed keywords

ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MONOCYTE; PRIORITY JOURNAL;

ANEMIA; BIOLOGICAL ASSAY; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; COMPARATIVE STUDY; ERYTHROPOIETIN; HEMOGLOBINS; HUMAN; LIVER NEOPLASMS; LYMPHOCYTES; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; TUBERCULOSIS, PULMONARY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0029117803     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1995.tb00267.x     Document Type: Article

References (27)

1. Haematological and iron‐related measurements in active pulmonary tuberculosis
2. The haematological and biochemical changes in severe pulmonary tuberculosis
3. The anemia of chronic disorders: Studies of marrow regulation and iron metabolism
4. The anemia of chronic disease
5. Plasma erythropoietin in health and disease
6. Erythropoiesis in the anaemia of rheumatoid arthritis
7. Serum immunoreactive erythropoietin in rheumatoid arthritis: Impaired response to anemia
8. Anaemia in rheumatoid arthritis: The role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness
9. Decreased erythropoietin response in patients with the anemia of cancer
10. Erythropoietin deficiency in the anaemia of chronic disorders
11. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages
12. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor
13. In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients
14. The role of tumour necrosis factor in the pathogenesis of tuberculosis and leprosy, and the relationship between tissue‐damaging pathology and production of agalactosyl IgG
15. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon‐γ
16. Tumor necrosis factor exerts dose‐dependent effects on erythropoiesis and myelopoiesis in vivo
17. The regulated expression of erythropoietin by two human hepatoma cell lines
18. Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications
19. TM– an automated hematology analyzer for today and tomorrow
20. Antigen‐antibody reaction in gels. IV. Types of reactions in coordinated systems of diffusion
21. Recommendations for measurement of serum iron in human blood
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
23. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis
24. Erythropoietin treatment of anemia associated with multiple myeloma
25. In vivo suppression of erythropoiesis by tumor necrosis factor‐α (TNF‐α): Reversal with exogenous erythropoietin (EPO)
26. Cachectin/tumor necrosis factor‐α alters red blood kinetics and induces anemia in vivo
27. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure